| Patents for C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087) |
|---|
| 08/31/2006 | US20060194767 Novel agents for preventing and treating disorders involving modulation of the RyR receptors |
| 08/24/2006 | WO2006004774A3 Laulimalide analogues as therapeutic agents |
| 08/17/2006 | CA2597044A1 5-fluoro-uracil immunoassay |
| 08/09/2006 | EP1687287A1 A novel process for ezetimibe intermediate |
| 08/03/2006 | US20060173178 Reducing 2-nitro-2'-carboxy-diphenylsulfide derivative in presence of hydrogen gas and reduction catalyst; subjecting 2-amino-2'-carboxy-diphenylsulfide derivative to dehydration-condensation to produce dibenzo[b,f][1,4]thiazepin-11-one compound |
| 08/03/2006 | US20060173058 Kcnq channel modulating compounds and their pharmaceutical use |
| 07/26/2006 | CN1809542A Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof. |
| 07/20/2006 | WO2006074940A2 Macrocyclic compounds and compositions useful as bace inhibitors |
| 07/20/2006 | CA2590664A1 Macrocyclic compounds and compositions useful as bace inhibitors |
| 07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
| 07/11/2006 | US7074776 Exposing bacterium to heterocyclic comound for controlling growth |
| 06/27/2006 | US7067675 reduction of the ketone group of 3-[5-(4-fluorophenyl)-1,5-dioxopentyl]-4-alkyl- or phenyl-2-oxa- or thiazolidin-one, -thione or -alkylimine with (-)-DIP chloride to obtain the corresponding 5-hydroxy- derivative |
| 06/27/2006 | US7067507 Macrocycles useful in the treatment of Alzheimer's disease |
| 06/20/2006 | US7064214 Reacting an amino-containing sulfinic acid with a metal hydrocarbon or halometal hydrocarbon to obtain a sterically pure product; pantoprazole; omeproazole; lansproazole; rabeproazoe; gastrointestinal disorders |
| 06/15/2006 | US20060128767 Methods of preparing sulfinamides and sulfoxides |
| 06/14/2006 | EP1668985A2 Nucleophile substituted ecteinascidins and N-oxide ecteinascidins |
| 06/07/2006 | EP0934065B1 Novel cryptophycin derivatives as anti-neoplastic agents |
| 05/30/2006 | US7053109 Aminediols for the treatment of Alzheimer's disease |
| 05/23/2006 | CA2169654C Wood preservative oxathiazines |
| 05/10/2006 | EP1654241A1 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof |
| 05/03/2006 | EP1107951B8 Homo- or copolymeric material based on sulfonylimides possessing a polymerizable group |
| 04/20/2006 | WO2006016610A3 Method of stabilizing amine oxide |
| 04/19/2006 | CN1252052C Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 04/12/2006 | EP1643860A1 Method for the production of a sweetener salt based on aspartame and acesulfame |
| 04/12/2006 | CN1757641A Oligomer with double-azo butter-fly shaped rigid large ring, and its prepn. method |
| 04/06/2006 | CA2581375A1 Specific kinase inhibitors |
| 04/05/2006 | EP1042963B1 Granular sweetener |
| 03/30/2006 | US20060069137 Novel process for ezetimibe intermediate |
| 03/22/2006 | EP1637138A2 Use of thiazolidinediones to prevent or delay onset of NIDDM |
| 03/21/2006 | CA2168357C Antibacterial and antifouling oxathiazines and their oxides |
| 03/14/2006 | US7011960 Substituted 2-amino-3-(2-amino-phenylsulfanyl)-propionic acids |
| 02/07/2006 | CA2268484C Cyclobutyl-aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 01/26/2006 | US20060019960 Antitumoral analogs of ET-743 |
| 01/19/2006 | US20060014962 Thiadiazole compound and use thereof |
| 01/18/2006 | CN1723205A Substituted benzoxazinones and uses thereof |
| 01/11/2006 | EP1107951B1 Homo- or copolymeric material based on sulfonylimides possessing a polymerizable group |
| 01/11/2006 | CN1235889C Cyanomethylene compounds, process for producing the same, and agricultural or horticultural bactericide |
| 01/05/2006 | US20060003978 beta-secretase inhibitors; to reduce A beta peptide formation; to reduce amyloid beta deposits or plaques; 12-[2-(3-Ethyl-benzylamino)-1-hydroxy-ethyl]-16-fluoro-2-oxa-8,11-diaza-bicyclo[12.3.1]octadeca-1(17),14(18),15-triene-7,10-dione |
| 12/14/2005 | EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use |
| 11/30/2005 | CN1229382C Hemisynthetic method and intermediate thereof |
| 11/24/2005 | US20050260597 Transfection reagents |
| 10/25/2005 | CA2304974C 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 10/12/2005 | CN1680344A Method for producing 3, 4-dihydro-1, 2, 3-oxathiazin-4-one-2, 2-dioxide compound or salt thereof |
| 10/05/2005 | CN1678298A Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder |
| 09/08/2005 | US20050194561 Anionic-sweetener-based ionic liquids and methods of use thereof |
| 08/24/2005 | EP1144394B1 1-heterocycle substituted diarylamines |
| 08/24/2005 | CN1659154A Method of preparing amine stereoisomers |
| 08/18/2005 | US20050182255 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide; cyclizing a beta-ketoamide-N-sulfonic acid with an acid anhydride |
| 08/17/2005 | EP1564211A1 Method for producing 3,4-Dihydro-1,2,3-Oxathiazin-4-one-2,2-Dioxide compound or salt thereof |
| 08/17/2005 | EP1562918A1 Substituted benzoxazinones and uses thereof |
| 08/17/2005 | EP1562916A1 Methods for preparing n-arylated oxazolidinones via a copper catalyzed cross coupling reaction |
| 08/11/2005 | WO2005072376A2 Anionic-sweetener-based ionic liquids and methods of use thereof |
| 08/11/2005 | WO2005034856A3 Targeted drug-formaldehyde conjugates and methods of making and using the same |
| 08/11/2005 | US20050176790 Pharmaceutical salts |
| 08/11/2005 | CA2554389A1 Anionic-sweetener-based ionic liquids and methods of use thereof |
| 08/04/2005 | US20050171165 reacting N-carboxyethoxybutyl-alanine with chlorosulfinyl imidazole to form N-sulfoxyanhydride, then with a silylated octahydroindole-1H-2-carboxylic acid to form perindopril; reacting perindopril with tert-butylamine to form perindopril erbumine; efficiency of industrial scale process; ACE inhibitor |
| 07/28/2005 | US20050165240 Chemical intermediates for production of sibutramine |
| 07/28/2005 | US20050164972 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | US20050164971 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 07/28/2005 | US20050164391 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/27/2005 | EP1287004B1 Synthetic process for the manufacture of an ecteinascidin compound |
| 07/20/2005 | CN1211386C Antitumoral analogue of Et-743 |
| 07/14/2005 | US20050153244 Sulfonate derivatives and the use thereof as latent acids |
| 07/13/2005 | CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 07/06/2005 | EP1280809B1 Antitumoral ecteinascidin derivatives |
| 06/15/2005 | CN1628268A Sulfonate derivatives and the use therof as latent acids |
| 06/09/2005 | US20050124069 Transfection reagents |
| 06/02/2005 | WO2005049592A1 A novel process for ezetimibe intermediate |
| 05/31/2005 | US6900322 Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 05/25/2005 | CN1202823C Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
| 05/25/2005 | CN1202821C Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (MIDDM) attack |
| 05/25/2005 | CN1202815C Delayed-action form of administration containing tramadol saccharinate |
| 05/11/2005 | CN1200700C Pharmaceutical tramadol salts |
| 04/27/2005 | CN1198809C Synthesis of acetyl sulfanilic acid and its potassium salt |
| 04/21/2005 | WO2005034856A2 Targeted drug-formaldehyde conjugates and methods of making and using the same |
| 03/23/2005 | EP1515709A2 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder |
| 02/24/2005 | US20050043373 Tyrosine phosphatase inhibitor; antidiabetic agents; insulin resistance; obesity |
| 02/03/2005 | DE10130504B4 Xanthin- und Phenazon-Acesulfam-H-Komplexe mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung Xanthine-phenazone and acesulfame-H-complexes with improved taste, process for their preparation and their use |
| 02/01/2005 | US6849648 Phenylene alkyne matrix metalloproteinase inhibitors |
| 02/01/2005 | US6849623 For use as human and veterinary medicine |
| 01/20/2005 | DE10330025A1 Verfahren zur Herstellung eines Süßstoffsalzes basierend auf Aspartam und Acesulfam A process for preparing a sweetener based on aspartame and acesulfame salt |
| 01/19/2005 | EP1497272A2 Method of preparing amine stereoisomers |
| 01/13/2005 | WO2005003106A1 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof |
| 01/13/2005 | WO2005002365A1 Method for the production of a sweetener salt based on aspartame and acesulfame |
| 01/13/2005 | US20050009805 Quaternary ammonium 1,4-benzothiazepinedione derivatives useful for treatment and prevention of hyperlipidemia, cholestasis-accompanying hepatopathy, particularly primary biliary cirrhosis and primary sclerosing cholangitis, and obesity and fatty liver. |
| 01/13/2005 | CA2529571A1 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof |
| 01/12/2005 | EP1496060A1 Antitumoral analogs of ET-743 |
| 01/05/2005 | CN1561203A Pharmaceutical salts |
| 11/24/2004 | EP1185536B1 Hemisynthetic method and intermediates thereof |
| 11/17/2004 | EP1289999B1 Antitumoral analogs of et-743 |
| 11/10/2004 | EP1475371A1 1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 11/04/2004 | WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use |
| 11/03/2004 | EP1472576A2 Sulfonate derivatives and the use therof as latent acids |
| 10/13/2004 | EP1207866B1 Delayed-action form of administration containing tramadol saccharinate |
| 10/07/2004 | US20040198974 applying deemed racemates to continuos enantioselective liquid chromatography like SMB (simulated moving bed); for industrial scale production of pure enantiomers of amino acids useful as intermediates in organic synthesis such as N-benzyloxycarbonyl-tert-leucine |
| 09/23/2004 | WO2004080377A2 Kcnq channel modulating compounds and their pharmaceutical use |
| 09/16/2004 | WO2003091207A3 Method of preparing amine stereoisomers |
| 09/09/2004 | US20040173224 Nicotine salts having improved taste, process for their preparation and their use |
| 09/08/2004 | EP1047678B1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 08/19/2004 | WO2004069844A1 Novel tricyclic oxazepine derivatives, method for production thereof and pharmaceutical compositions comprising the same |